← Assessments

A22-49·Doravirine/lamivudine/ tenofovir disoproxil·Immune system and infections

Initial/ Published 2022-08-01

Abstract

Doravirine/lamivudine/ tenofovir disoproxil for Immune system and infections. IQWiG concluded benefit not proven.

Source

Source markdown is not available for this project.